Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (CSE:PHRX)

PharmaDrug Announces Issuance of Debenture Units

Newsfile November 15, 2024

PharmaDrug Announces Proposed Issuance of Debenture Units

Newsfile October 31, 2024

PharmaDrug's Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases

Newsfile October 31, 2024

PharmaDrug's Sairiyo Therapuetics Announces Initiation of Study Start-Up Activities and Design for Clinical Trial of PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases

Newsfile September 19, 2024

PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases

Newsfile August 28, 2024

PharmaTher's Sairiyo Therapeutics Announces Independent Screening Identifying Cepharanthine's Potential to Bind to Monkeypox (Mpox) Proteins

GlobeNewswire August 21, 2024

PharmaDrug's Sairiyo Therapuetics Announces Independent Screening Identifying Cepharanthine's Potential to Bind to Monkeypox (Mpox) Proteins

Newsfile August 21, 2024

PharmaTher's Sairiyo Therapeutics Receives Approval to Initiate a Phase 1 Human Clinical Trial of PD-001 (Reformulated Cepharanthine)

GlobeNewswire August 19, 2024

PharmaDrug's Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine

Newsfile August 19, 2024

Opinion & Analysis (CSE:PHRX)

No current opinion is available.

Bullboard Posts (CSE:PHRX)

Nice Day, huge buying volume today over 3mm shares...

Large buying volume starting..picked up another 500k at half cent...something brewing with this on a potential news announcement. Should...
Guytorule - 1 day ago

RE:RE:Sellers

Good points, I love the reassurance and the cup is half full. Was thinking of taking out the .01. However with no news in forever and...
Tommyjohn - 8 days ago

RE:Sellers

Keep in mind they are separate company's. As for today's action with Phrx , one can put a positive spin with this sell off today...
Guytorule - 8 days ago

Sellers

Looks like bids are low and asks are high. I would think the opposite with wahts happening with THRM. In witch they have interest in!
Tommyjohn - 13 days ago

RE:RE:No news

Yes i assume the same, just a waiting game. Here's to a good start to the summer.
Tommyjohn - April 7, 2025

RE:No news

Not odd, just timing required in my opinion. My take is PharamaTher (PHRM) partner with Sairiyo will soon get their FDA approval very...
Guytorule - April 5, 2025